publication date: Jul. 13, 2018

In Brief

Gerstle named chief of Pediatric Surgery Service at MSK

Pediatric surgeon J. Ted Gerstle was named chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center.

Gerstle most recently served as director of the Surgical Oncology Program in the Division of General and Thoracic Surgery at the Hospital for Sick Children, affiliated with the University of Toronto.

Gerstle formally assumes his new role as Michael La Quaglia steps down after 30 years. La Quaglia will remain at MSK.

Gerstle specializes in the treatment of solid tumors of the chest and abdomen, particularly neuroblastoma. At SickKids, he was an associate scientist in translational medicine at the Peter Gilgan Centre for Research and Learning and an associate professor of surgery at the University of Toronto.

He has focused his research efforts on understanding the ways that high-intensity focused ultrasound treats solid tumors in preclinical models of disease and combining its effects with drug delivery and immunotherapy, with the ultimate goal of bringing such combined treatments to the bedside.

Gerstle received his medical degree in 1988 from Dartmouth Medical School. He trained at Penn State University in general surgery from 1988 to 1995, which included a postdoctoral research fellowship. He completed a pediatric surgery fellowship at SickKids in 1998, after which he became a full-time staff member.

In addition to his clinical and academic focus on pediatric cancer, Gerstle has been actively involved in global child health projects in sub-Saharan Africa, particularly Ethiopia. In January 2011 he became the Surgical Director for the Qatar Project, which was a joint initiative with SickKids International and the state of Qatar … Continue reading Gerstle named chief of Pediatric Surgery Service at MSK

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.